Hikma Pharma Full-Year Profit Rises 19%

Hikma Pharmaceuticals Plc

reported a 19% surge in its full-year profit. Hikma's profit attributable to shareholders climbed to $120.5 million, up from $100.9 million in the year-ago period. Its revenue rose 21% to $1.11 billion.